VTE (VENOUS THROMBOEMBOLISM)
Clinical trials for VTE (VENOUS THROMBOEMBOLISM) explained in plain language.
Never miss a new study
Get alerted when new VTE (VENOUS THROMBOEMBOLISM) trials appear
Sign up with your email to follow new studies for VTE (VENOUS THROMBOEMBOLISM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New care plan aims to tame lung cancer Drug's side effects
Disease control Not yet recruitingThis study tests a special care plan (CEPM) to help manage side effects like skin rash and infusion reactions in people with advanced EGFR-mutated lung cancer who are taking the drug amivantamab. About 122 Chinese adults will join to see if this plan improves their quality of lif…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: PHASE4 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated May 26, 2026 07:45 UTC
-
Which blood thinner works best after weight loss surgery? new trial aims to find out
Prevention Not yet recruitingThis study compares two blood-thinning injections, tinzaparin and enoxaparin, to see which better prevents dangerous blood clots after weight loss surgery. About 180 adults having laparoscopic bariatric surgery will be randomly assigned to receive one of the two injections daily …
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Phase: NA • Sponsor: University College Dublin • Aim: Prevention
Last updated May 26, 2026 07:41 UTC
-
Blood clots after limb trauma may lead to lasting pain, new study suggests
Knowledge-focused Not yet recruitingThis study looks at whether blood clots (VTE) that form after a serious arm or leg injury increase the risk of long-term pain. Researchers will follow 150 adults for six months after their injury, comparing pain levels in those who develop clots and those who don't. The goal is t…
Matched conditions: VTE (VENOUS THROMBOEMBOLISM)
Sponsor: Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) • Aim: Knowledge-focused
Last updated May 26, 2026 07:43 UTC